AI consulting and development

AI that ships.
Experts in the loop.

Amia Agency designs, builds and runs AI for pharma, biotech and regulated enterprises. Agents, regulatory workflows and automation, delivered as finished work and reviewed by people who are accountable for it.

  • Source-traced
  • Expert-reviewed
  • On your cloud
  • 21 CFR Part 11-aware
DOCSTOOLSDATAEXPERTREVIEW AGENT
How we deliver

Assess. Pilot. Build. Run.

A four-step model that gets AI into production on your infrastructure, with accountable experts reviewing the work before it reaches you.

Assess

We agree the scope, the question you need answered and the review cycles included, in writing.

Pilot

A focused pilot proves the workflow on your data before any broader build or commitment.

Build and deploy

We build the production system on your infrastructure, with evaluation and monitoring baked in.

Run and support

We operate, monitor and improve it: model updates, performance tracking and expert review on call.

Client voices

Proven where the stakes are highest.

The tool demonstrated strong accuracy against the client's golden output, including placeholder filling and table population, and showed a reproducible, traceable approach to report generation.
Chief Scientific Officer
$6B global leader in bioprocessing technologies and biopharmaceutical manufacturing solutions
Amia.ai demonstrated exceptional responsiveness to evolving requirements, rapidly adapted to our specific technical documentation needs, and maintained a collaborative, solutions-oriented team culture throughout the engagement. Their ability to execute and adapt made them a strong technology partner.
Executive Director
Large biopharma company, Massachusetts
Amia's MedNova IND gap analysis identified several critical gaps and missing elements that our regulatory writers had overlooked. Without these findings, we could have submitted an IND containing incomplete or inaccurate information, potentially leading to costly delays and additional FDA scrutiny.
Chief Executive Officer
San Diego-based clinical-stage biotechnology company

Company and executive identities are available to qualified investors under a signed NDA, subject to disclosure authorization. Testimonials 1 and 2 are from the same enterprise engagement.

Questions

What people ask first.

What kinds of projects do you take on?

Agentic AI and LLM apps, regulatory and pharma AI workflows, enterprise automation for document-heavy work, and AI strategy and readiness. We lead with pharma and life sciences and bring the same governed approach to other regulated industries.

Do experts review the work?

Yes. Software drafts, experts decide. In our regulatory work, an expert reviews every finding before it reaches you, and every statement is linked back to its source.

How is pricing set?

Every engagement is scoped in writing and priced after a scoping call. There are no seats or licenses; you pay for the deliverable, and strategy is included in the engagement.

Where does the system run, and who sees our data?

On your infrastructure: AWS, Azure or GCP, or on premise by arrangement. Access is role-based and activity is logged. We are happy to sign an NDA before you share anything.

Can we see examples of your work?

Yes. See the portfolio for case studies and demonstrations. Client names are anonymized, and additional project details and professional references may be provided upon request, subject to confidentiality and prior approval.

How quickly can we start?

Most engagements begin with a 30-minute scoping call and a written scope. If you have a deadline, say so in the project brief and we will tell you plainly what is realistic.

Ready when you are

Know where you stand
before you build.

Tell us about your AI initiative or your next filing. We will tell you what a scoped engagement would cover and how it would be priced.